Accendra Health Inc expected to post a loss of 9 cents a share - Earnings Preview

Accendra Health

07/08/2026 16:37

Accendra Health Inc ACH.N, ACH is expected to  show a fall in quarterly revenue when it reports  results on August 10 for the period ending June 30 2026
The Glen Allen Virginia-based  company is expected to report a 8.0% decrease in revenue to $627.306 million from $681.92 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Accendra Health Inc is for a loss of 9 cents per share. 
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and 2 "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Accendra Health Inc is $4.50, about 54.1% above its last closing price of $2.92
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.10
-0.10
-0.04
Beat
60.5
Dec. 31 2026
0.22
0.22
0.21
Missed
-4.9
Sep. 30 2025
0.23
0.23
0.25
Beat
7.8​
Jun. 30 2025
0.28
0.27
0.26
Missed
-5.3
​​Mar. 31 2025
0.19
0.20
0.23
Beat
17.8
Dec. 31 2024
0.52
0.52
0.55
Beat
5.9​
Sep. 30 2024
0.42
0.41
0.42
Beat
1.6
Jun. 30 2024
0.34
0.33
0.36
Beat
9.8
This summary was machine generated August 7 at 15:37 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)